The Cancer Prevention and Research Institute of Texas has awarded eight grants totaling more than $13 million dedicated to expanding access to cancer clinical trials in Texas, including one new award that will strengthen clinical trial network infrastructure, two first-of-their-kind CPRIT awards to encourage increased participation in clinical trials and five awards that support the next generation of promising clinical investigators.
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
